M2e, the human Transmembrane Domain of M2 Protein (TFA), encompasses the 23 extracellular residues of M2, the third integral membrane protein of Influenza A, and exhibits remarkable conservation across all strains of human influenza A. This conservation positions M2e, human TFA as a promising and adaptable vaccine candidate capable of providing protection against all strains of human influenza A [1].